Dr. Chelsea Taber Bowman, MD

Dr. Bowman practices at Danville Center Imaging in Danville, California.

Dr. Bowman's NPI, 1033485958, was assigned on March 25, 2012. Dr. Bowman graduated from UCSF School of Medicine in 2012. Dr. Bowman's California license number on file is A127499.

Dr. Bowman's primary practice is Danville Center Imaging, at 915 San Ramon Valley Blvd, Danville, CA 94526. The practice phone is (650) 853-2902.

Dr. Bowman's primary practice is Danville Center Imaging in Danville, California. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Bowman to 1 more group practice or clinic and 1 home health agency, each named with a free account. Dr. Bowman's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bowman practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bowman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Bowman is board certified in internal medicine by the American Board of Internal Medicine. Dr. Bowman has a license on file in California.

Dmand AI lists acid reflux, arthritis, atrial fibrillation and flutter, cardiomyopathy, chronic anemia, chronic diabetes, chronic hypertension and chronic kidney disease among the conditions Dr. Bowman treats.

CMS data shows 319 Medicare services from Dr. Bowman across 8 procedure codes in 2024, for 129 Medicare patients. Medicare paid $31,028 for them. Every service was in an office.

CMS counts 129 Medicare patients who saw Dr. Bowman in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.78, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bowman's median patient age at 50, with 72% women.

In 2024, Dr. Bowman wrote 1,222 Medicare Part D claims for 133 patients. 90% of them were for generic drugs. CMS names the drug for 912 of them, across 30 drugs with 11 or more claims each, at $35,992 in total drug cost. In 2023, CMS named 963 claims across 36 drugs.

Dr. Bowman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bowman as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Bowman, published from 2011 to 2018. 2011 was the busiest year, with 2. Dr. Bowman's most frequent co-authors are Anthony Azakie, MD, Anthony J. Barkovich, MD and Hannah C. Glass, MD.

CMS Open Payments shows 1 general payment to Dr. Bowman from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $19.

Dmand AI lists 6 awards for Dr. Bowman, most recently Quality Innovation and Safety Challenge Project Award Winner in 2014.

Dr. Bowman graduated from UCSF School of Medicine in 2012.

Dr. Bowman is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.